Provider
Pseudobulbar Affect (PBA) - Medicaid
Prior Authorization, Quantity Limit
Program effective Date: Apr 01, 2025
Search Results
Displaying 1881 - 1890 of 3661 results
Provider
Pseudobulbar Affect (PBA) - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Apr 01, 2025
Provider
Kerendia® - Medicaid - Effective Date 03/01/2025
Prior Authorization, Quantity Limit
Program effective Date: Mar 01, 2025
Provider
P31-22 eviCore Healthcare Specialty Utilization Management (UM) Program - Laboratory Management Clinical Guideline Updates for Fully Insured Commercial and Medicare Advantage Subscribers
Program effective Date: May 02, 2022
Provider
P32-22 Medical Policy Updates: Coupe Health and Self-Funded Benefit Plans managed by Blue Cross and Blue Shield of Alabama
Program effective Date: May 02, 2022
Provider
Vascepa® (icosapent ethyl) - Medicaid
Prior Authorization, Quantity Limit
Program effective Date: Sep 01, 2024
Provider
Vascepa® (icosapent ethyl) - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Sep 01, 2024
Provider
QP42-22 Reminder: Self-Administered Drug Coverage for Medicare Members
Program effective Date: May 25, 2022
Provider
QP43-22 Reminder: Medical Drug Coding for Botulinum Toxins
Program effective Date: May 25, 2022
Provider
P33-22 New Medical, Medical Drug and Behavioral Health Policy Management Updates—Effective July 4, 2022
Program effective Date: May 02, 2022